2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Publication
, Journal Article
Grundy, SM; Stone, NJ; Bailey, AL; Beam, C; Birtcher, KK; Blumenthal, RS; Braun, LT; de Ferranti, S; Faiella-Tommasino, J; Forman, DE ...
Published in: J Am Coll Cardiol
June 25, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
June 25, 2019
Volume
73
Issue
24
Start / End Page
3168 / 3209
Location
United States
Related Subject Headings
- United States
- Risk Reduction Behavior
- Risk Assessment
- PCSK9 Inhibitors
- Medication Therapy Management
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Ezetimibe
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., … Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 73(24), 3168–3209. https://doi.org/10.1016/j.jacc.2018.11.002
Grundy, Scott M., Neil J. Stone, Alison L. Bailey, Craig Beam, Kim K. Birtcher, Roger S. Blumenthal, Lynne T. Braun, et al. “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” J Am Coll Cardiol 73, no. 24 (June 25, 2019): 3168–3209. https://doi.org/10.1016/j.jacc.2018.11.002.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Jun 25;73(24):3168–209.
Grundy, Scott M., et al. “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.” J Am Coll Cardiol, vol. 73, no. 24, June 2019, pp. 3168–209. Pubmed, doi:10.1016/j.jacc.2018.11.002.
Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 Jun 25;73(24):3168–3209.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
June 25, 2019
Volume
73
Issue
24
Start / End Page
3168 / 3209
Location
United States
Related Subject Headings
- United States
- Risk Reduction Behavior
- Risk Assessment
- PCSK9 Inhibitors
- Medication Therapy Management
- Hypercholesterolemia
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Ezetimibe
- Cardiovascular System & Hematology